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ABSTRACT
Introduction: Necrotizing fasciitis (NF) is a rare
complication in pregnant women. There have
been no population-level data reported to date
on its epidemiology, clinical features, resource
utilization, and outcomes.
Methods: This was a retrospective, population-
based cohort study, using the Texas Inpatient
Public Use Data File to identify pregnancy-
associated hospitalizations for the years
2001–2010. Hospitalizations with a diagnosis
of NF were then identified using the
International Classification of Diseases, Ninth
Revision, Clinical Modification code 728.86.
Denominator data for incidence estimates
were derived from the Texas Center for Health
Statistics reports of live births, abortions and
fetal deaths, and previously reported
population-based, age-specific linkage data on
miscarriage, and were used to estimate the
annual total number of pregnancies (TEP). The
incidence of pregnancy-associated NF (PANF),
hospitalization type, clinical features, resource
utilization and outcomes were examined.
Results: There were 4,060,201 pregnancy-
associated hospitalizations and 148 PANF
hospitalizations during study period.
Postpartum hospitalizations accounted for
82.4% of all PANF events, and intensive care
unit care was required in 61.5%. The key trends
noted between 2001–2002 and 2009–2010
included rising incidence of PANF from 1.1 vs.
3.8 per 100,000 TEP-years (P = 0.0001), chronic
comorbidities 0% vs. 31.7% (P = 0.0777), and
development of organ failure in 9.1% vs. 31.7%
(P = 0.0302). There was no significant change in
total hospital charges or hospital length of stay.
Three patients (2%) died in the hospital and
55% of survivors had routine home discharge.
Conclusions: The present cohort of PANF is the
largest reported to date. The incidence of PANF
rose nearly 3.5-fold over the past decade, with
most events developing following delivery
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hospitalization. Chronic illness has been
increasingly present, along with rising severity
of illness. The majority of patients required ICU
care. Hospital mortality was lower than that
reported for NF in the general population. The
sources of the observed findings require further
study.
Keywords: Mortality; Necrotizing fasciitis;
Organ failure; Pregnancy; Resource utilization
INTRODUCTION
Pregnancy is associated with an increased risk of
infection, in part due to various pregnancy-
related mechanical and physiological changes
[1]. In addition, recent evidence suggests that
pregnancy is associated with an immunological
shift away from inflammatory processes and
inflammatory cytokines and toward a more
anti-inflammatory immunologic state [2].
These changes may also play a role in the
maternal response to overwhelming infection
and subsequent sepsis [2].
Despite improvements in medical care and
preventive measures, infectious complications
remain a major source of pregnancy-related
mortality in both developing and developed
countries worldwide [3], reported to be the 5th
most common cause of maternal death [1]. A
recent review conducted by the World Health
Organization has estimated the global burden
of maternal sepsis to be more than 6,900,000
cases per year [4].
Necrotizing fasciitis (NF) is a soft tissue
infection manifesting as necrosis of
subcutaneous tissues and fascia. Although rare,
NF commonly results in severe and often fatal
illness with high resource utilization. Case
fatality associated with NF has been reported
to exceed 40% in single-center studies [5], while
reports on larger cohorts described case fatality
around 5–12% [6, 7].
Pregnancy-associated NF (PANF) has been
described in multiple reports. However, because
of its rarity, descriptions of NF in the obstetric
population to date were limited to case reports
[8–10] or small case series [11, 12], and was
absent in a population study of invasive
streptococcal infections in the postpartum
period [13]. Thus, the epidemiology of PANF is
presently unknown, with limited data on its
clinical characteristics, resource utilization and
outcomes.
The aim of this first population-level study to
date, to the authors’ knowledge, was to examine
the epidemiological, clinical, resource
utilization, outcome characteristics, and
secular trends of pregnancy-associated NF.
MATERIALS AND METHODS
Data Sources
Data were obtained from the Texas Inpatient
Public Use Data File (TIPUDF), a longitudinal
data set maintained by the Texas Department of
State Health Services [14]. The data set includes
detailed de-identified inpatient discharge data
from all state-licensed hospitals, with the
exception of those exempt by state statute
from reporting to the Texas Health Care
Information Collection. Exempt hospitals
include (a) those that do not seek insurance
payment or government reimbursement and
(b) Selected rural providers, based on bed
number and local county population [14]. The
facilities included in the mandated report
account for 93–97% of all hospital discharges.
The TIPUDF data set includes demographic,
clinical, resource utilization, and outcome
information. The data set includes up to 25
308 Infect Dis Ther (2014) 3:307–320
discharge diagnoses, and up to 25 procedures,
coded using the International Classification of
Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM).
Data on the annual number of pregnancies,
live births, abortions, fetal deaths, and their
related demographic characteristics were
obtained from the Vital Statistics Annual
Reports, compiled by the Center for Health
Statistics at the Texas Department of State
Health Services [15].
The TIPUDF is a publicly available, de-
identified data set, and therefore this study
was determined to be exempt from formal
review by the Texas Tech Health Sciences
Center Institutional Review Board. This article
does not involve any new studies with human
or animal subjects performed by any of the
authors.
Study Population
Texas residents with pregnancy-related
hospitalizations between 2001 and 2010 were
identified using ICD-9-CM codes (Supplemental
Appendix 1). Subsequently, an ICD-9-CM code
728.86 was used to identify patients with a
primary or secondary diagnosis of NF.
Data Collection
Data were collected on patients’ age, race
(categorized as non-Hispanic black [black],
non-Hispanic white [white], Hispanic, and
other), health insurance (categorized as
private, Medicaid, uninsured, and other),
chronic comorbid conditions (based on the
Deyo–Charlson index [16]), obesity, smoking,
drug and alcohol abuse, other sites of infection
(Supplementary Appendix 2), reported
microorganisms (Supplementary Appendix 3),
type and number of failing organs
(Supplementary Appendix 4), admission to an
intensive care unit (ICU), life-support
interventions (mechanical ventilation, central
venous catheterization, hemodialysis, and
tracheostomy) (Supplementary Appendix 5),
total hospital charges, hospital length of stay,
and disposition at the end of hospitalization.
Severity of illness was based on the number of
failing/dysfunctional organs (organ failure
[OF]), as modeled by the coding system
reported by Lagu et al. [17].
Type of pregnancy-associated
hospitalizations were categorized into the
following mutually exclusive, hierarchical
groups, using pregnancy-associated ICD-9-CM
codes: (a) fetal loss (pregnancies with abortive
outcome, excluding induced abortion),
(b) induced abortion (c), delivery (based on
the approach described by Kuklina and
colleagues [18]), (d) postpartum
(hospitalizations with a an ICD-9-CM code for
puerperal complications, without pregnancy-
related diagnosis codes of groups a–c), and
(e) antepartum (hospitalization with
pregnancy-related diagnosis, but without
pregnancy-related diagnosis codes of groups
a–d).
Outcomes
The primary outcome was hospital mortality.
Secondary outcomes included number and type
of OF, resource utilization, and disposition
among hospital survivors.
Data Analysis
To derive the incidence of PANF events across
the full spectrum of pregnancy outcomes, the
number of annual total estimated pregnancies
(TEP) was calculated. TEP was a combination of
the number of live births, fetal deaths (events
Infect Dis Ther (2014) 3:307–320 309
reported by the state, occurring at C20 weeks of
gestation), induced abortions, and estimates of
the annual number of fetal losses (events
occurring at \20 weeks of gestation, including
miscarriage, ectopic and molar pregnancies).
The estimation of the annual number of fetal
losses was based on the study by Nybo Anderson
et al. [19]. This was a population-based linkage
study of the association of maternal age with
fetal loss, reporting rates of fetal loss for
pregnancies intended to be carried to term,
thus adjusting for overestimates resulting from
fetal loss events prior to planned abortion. The
reported number of live births and fetal deaths
was used to derive the number of fetal losses.
Because TIPUDF provides discharge-level, rather
than patient-level information, PANF events
were reported as number of hospitalizations.
Incidence rates of patients’ hospitalizations
with a diagnosis of PANF per 100,000 TEP
were calculated. Direct age adjustment using
5-year age strata was performed. Two PANF
hospitalizations associated with fetal loss/
induced abortion could not be adequately
classified to only one group (that is, either
fetal loss or induced abortion), because their
only pregnancy-associated ICD-9-CM code was
639.XX (complications following abortion and
ectopic and molar pregnancies). A ‘‘worst-case’’
upper incidence estimate (reported
parenthetically) was recalculated for both
fetal loss and induced abortion PANF
hospitalizations, assuming alternately that the
unclassified hospitalizations were only fetal
loss- or only induced abortion related.
Multiple sensitivity analyses were performed
to examine the robustness of the incidence
estimates. Although TIPUDF is reported to
include 93–97% of annual hospital discharges,
the annual incidence of PANF was reanalyzed,
assuming the data set captures only 90% of all
hospital discharges. In addition, because the
non-reporting hospitals are skewed toward
rural facilities, potentially affecting care
patterns, we assumed the incidence of PANF
is higher, up to 50% above that for reporting
hospitals.
In addition, the incidence of PANF was
reanalyzed, assuming that the rate of fetal loss
among Texas residents is twice as high as the
13.5% rate reported by Nybo et al. [19]. This
higher rate exceeds the upper estimated rate of
fetal loss of 22% reported in a recent systematic
review by Ammon Avalos et al. [20].
The mortality associated with PANF was
examined as case fatality (defined as the
number of PANF hospitalizations who died in
the hospital divided by the total number of
PANF hospitalizations for an examined group).
Group data were reported as numbers
(percentages) for categorical variables and
mean (standard deviation [SD]) or median
(interquartile range [IQR]) for continuous
variables, as appropriate. Ninety-five percent
confidence intervals (95% CI) were calculated.
Distribution of normality was examined by
Kolmogorov–Smirnov test. Categorical data
were compared by 2-sided X2. Mann–Whitney
U test and t test were used to compare
continuous data, as appropriate. A regression
analysis was used to explore the annual trends
of PANF incidence. When examining trends of
key characteristics at the start vs. end of past
decade combined 2-year data were used to
enhance precision of comparisons. Total
hospital charges were examined using
inflation-adjusted (2010) dollars. All statistical
analyses were performed using MedCalc version
12.7.0 (MedCalc Software, Ostend, Belgium)
and SAS version 9.3 (SAS Institute, Cary, NC,
USA). A 2-sided P value \0.05 was considered
statistically significant.
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RESULTS
There were 4,060,201 pregnancy-associated
hospitalizations and 148 PANF
hospitalizations, with 5,347,084 total
estimated pregnancies during the 2001–2010
period. The characteristics of PANF
hospitalizations are detailed in Table 1.
Hispanic women constituted the largest group
(42.6%) of PANF hospitalizations, reflecting the
obstetric population in Texas. Medicaid was the
most common type of health insurance
(51.4%). Only a minority of women (17.6%)
had reported chronic comorbid conditions,
with diabetes mellitus noted in 50% of the
latter. Drug and tobacco abuse were rare.
Obesity was reported in 22.3% of PANF
hospitalizations. Postpartum hospitalizations
accounted for 82.4% of all NF events, while NF
hospitalizations associated with miscarriage or
abortion were rare. The incidence of PANF
hospitalizations rose by 14% per year.
Other (non-NF) sites of infection were
reported in 40 (27%) PANF hospitalizations.
The most common reported sites included
the genital tract (14.2%), respiratory, and
intra-abdominal infections (6.8% each).
Microbiology data were reported in 61 (41.2%)
hospitalizations. When analysis was restricted
to PANF hospitalizations with reported
microbiology data, who had no other reported
sites of infection (n = 52), single bacteria was
predominant, noted in 65.4%, being
polymicrobial in the remainder. The following
microbial isolates are restricted to these 52
PANF hospitalizations. Gram-positive bacteria
were reported in 90.4%, Gram-negative bacteria
in 36.5%, and anaerobes in 2%. No fungi were
reported. Among hospitalizations with reported
Gram-positive bacteria, streptococcal species
were reported in 55.3% and staphylococcal
Table 1 Characteristics of hospitalizations with
pregnancy-associated necrotizing fasciitis
Characteristic n 5 148














Chronic comorbidities, n (%)a
Any 26 (17.6)
Diabetes mellitus 13 (8.8)
Chronic pulmonary disease 4 (2.7)
Chronic kidney disease 3 (2.0)
Deyo–Charlson score (mean [SD]) 0.27 (0.69)
Other conditions, n (%)b
Smoking 5 (3.4)
Drug abuse 3 (2.0)
Alcohol abuse 0 (0)
Obesity 33 (22.3)
Type of pregnancy-related hospitalization, n (%)
Fetal lossc 1 (0.7)/2 (1.4)




n, Number of patients; ICD-9-CM, International Classiﬁcation of
Diseases, Ninth Revision, Clinical Modiﬁcation; SD, standard
deviation
a Based on conditions included in the Deyo–Charlson
comorbidity index
b Refers to comorbid conditions not included in the Deyo–
Charlson index
c There was 1 miscarriage/abortion-related hospitalization whose
only pregnancy-related diagnosis was ICD-9-CM code 639.XX,
precluding separation to one group; upper estimates of the
number and percent of fetal loss hospitalizations were provided
after the slash for each
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species in 51.1%. Group A streptococci were
reported in 6 (11.5%) PANF hospitalizations
without non-NF infection site. Among
hospitalizations with reported Gram-negative
bacteria, Proteus species (52.6 %) and E. Coli
(36.8 %) were the most common isolates.
The key changes of epidemiological, clinical,
and resource utilization features among PANF
hospitalizations between 2001–2002 and
2009–2010 are outlined in Table 2. The
incidence of PANF hospitalizations rose from
1.1 to 3.8 per 100,000 TEP-years (P = 0.0001),
and was most common among black women.
Estimates of the annual incidence of PANF
remained unchanged on reanalyzing the data,
assuming increased rates of fetal loss (P values
ranging from 0.6612 to 0.8319) or with lower
rate of statewide reported hospitalization,
coupled with higher rates of PANF in
unreported hospitalizations (P values ranging
from 0.5637 to 0.7815). No significant change
was noted among women aged 35 years or older
(P = 0.2638). Chronic comorbidities were
reported in nearly a third of PANF
hospitalizations at the end of last decade,
while none were reported in 2001–2002. The
rate of reported obesity rose more than
threefold, though the change did not reach
statistical significance. One or more OFs were
reported in 43 (29.1%) PANF hospitalizations,
rising from 9.1% to 31.7% during past decade
(P = 0.0302). OF was reported nearly twice as
commonly among PANF hospitalizations with
chronic comorbidities, as compared to those
without (46.2% vs. 24.6%; P = 0.0483). Use of
life-support interventions rose during study
period, but did not reach statistical significance.
Admission to an ICU was required in 61.5%
of PANF hospitalizations. Though down-
trending over the past decade, there was no
significant change in hospital length of stay
(P = 0.4863) and total hospital charges
(P = 0.3642) among PANF patients. The
average inflation-adjusted (2010 dollars) total
hospital charges per PANF hospitalization were
$102,434.
Three (2%) patients died during
hospitalization. Among survivors, 80 (55%)
had routine home discharge, 50 (34%)
required home health care, and 14 (10%) were
discharged to another facility. No change was
found in transfers to other institutions over the
past decade (data not shown).
DISCUSSION
The incidence of PANF hospitalizations has
risen nearly 3.5-fold over the past decade.
PANF was infrequently associated with chronic
comorbidity, while showing increased severity
of illness over time. Most women with PANF in
our cohort required admission to an ICU, with a
trend of increasing use of life-support
interventions. PANF required prolonged
hospitalization and high hospital charges.
Case fatality was low in the present cohort.
However, hospital survivors sustained persistent
morbidity with only about half having a routine
home discharge.
The present study is, to the authors’
knowledge, the first population-level
examination of PANF, reflecting the rarity of
this complication in obstetric patients. These
findings of rising PANF incidence from about 1
to nearly 4 hospitalizations per 100,000 TEP
cannot be directly compared with reports of NF
in the general position, in part due to
differences in age, prevalence of chronic
comorbid conditions and preceding clinical
interventions. A commonly cited multistate
incidence estimate of NF in the US is 4 per
100,000, based on the report by Ellis Simonsen
et al. [21] using administrative data from 1997
to 2002. Because the incidence of NF rises with
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age [6, 22], it may be hypothesized that at the
end of last decade the incidence of PANF in this
cohort may have exceeded same-age
development of NF in the general population.
Markedly, lower incidence of NF was found by
Mulla et al. [23] in another population study,
using similar approach, with NF reported in 1.3
per 100,000 hospital discharges in Florida in
2001. However, the investigators focused only
on NF as primary diagnosis. There are no more
recent population-level data on the incidence of
NF in the United States (US). Further studies are
needed to corroborate our findings.
Several possible explanations should be
considered for the apparent rise of incidence
of PANF in this cohort. These findings may
reflect increasing diagnosis of less severe skin
and soft tissue infections as NF over time.
However, this explanation is not supported by
the evidence of rising severity of illness,
matched by trends in use of life-support
interventions, and unchanged resource
utilization.
Increased clinician awareness of a specific
clinical condition should be considered as an
alternative source of an apparent rise in its
Table 2 Key changes of epidemiology, patient characteristics, resource utilization and outcomes of hospitalizations with
pregnancy-associated necrotizing fasciitis
Variable 2001–2002 (n5 11) 2009–2010 (n5 41) p
Age-adjusted incidence (per 105 TEP-years)
All 1.1 3.8 0.0001
Hispanic 0.6 3.5 0.0023
White 1.6 4.2 0.0396
Black 0.8 4.9 0.0498
Age C35 years (%) 63.6 39 0.2638
Chronic comorbidity (%)a 0 31.7 0.0777
Obesity (%) 9.1 29.3 0.3271
C1 Organ failures (%) 9.1 31.7 0.0302
Procedures
Mechanical ventilation, (%) 0 22 0.2077
Central venous catheterization (%) 36.4 46.3 0.8027
Hemodialysis (%) 0 2.4 0.4757
Hospital length of stay (days)
Mean (SD) 16.2 [11.1] 12.1 [7.3]
Median [IQR] 12 [6–27] 11 [8–13] 0.4867
Hospital charges
(Dollars, median [IQR]) 88,216 [65,982–133,314] 71,161 [51,497–119,577] 0.3642
TEP Total estimated pregnancies, IQR interquartile range, n number of patients, SD standard deviation
a Chronic comorbidities from the Deyo–Charlson index
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incidence. However, this explanation is
implausible in the case of PANF, as it remains
a very rare complication, as evidenced in the
current study with NF codes used in 0.004% of
pregnancy-associated hospitalizations, and with
most clinicians and hospitals in the state never
encountering a PANF patient. It may thus be
hypothesized that the present findings reflect
actual rise in the incidence of PANF in the state.
There are several possible explanations for rising
incidence of PANF in this cohort. Chronic
comorbidities, well known to increase risk of
infection and NF [24] were present in nearly
one-third of PANF hospitalizations at the end of
study period. In addition, obesity was
increasingly present in our cohort. Obesity is a
well-known risk factor for NF [6], has been
associated with increased risk of infections in
pregnancy [25], and is more specifically linked
with increasing risk of cesarean section [25, 26].
The latter has been often associated with PANF
in prior reports [11, 12]. It is likely that the rate
of obesity was underreported in this cohort, as
can be the case in administrative data sets [27].
The rising rate of cesarean section in the US
over the past decade [28] may have contributed
to the rising incidence of PANF, a hypothesis
supported by our findings of the majority of
reported NF events occurring as postpartum
hospitalizations. However, the de-identified
structure of the administrative data set used in
the present study precludes linking postpartum
hospitalizations to specific preceding delivery
hospitalizations to confirm this hypothesis.
Additional study in other states and nationally
is required to further elucidate the
epidemiology of PANF.
Findings of the race/ethnicity composition
of the women in the present study and the
predominance of Medicaid as the most
common type of health insurance, reflect the
obstetric population in Texas, but may vary in
other settings. The age distribution noted in the
present cohort is in line with the majority of
pregnancies occurring in the 20–34 years age
group.
The majority of PANF hospitalizations did
not have reported chronic comorbidities. This
finding contrasts reports on NF in the general
population, with the majority of patients
having one or more chronic illnesses [6].
However, when chronic comorbidities were
present in patients, diabetes was the
predominant one, similar to reports in the
general population with NF [6, 7]. These
results are in agreement with reported cases
and case series of PANF, with most affected
patients without chronic illness. Obesity was
reported in about 1 in 5 of our patients in this
study and, as noted earlier, may have been
underreported. On the other hand, obesity was
prevalent in prior case series of PANF, reported
in 67% [11] and 83% [12] of their patients.
The present study revealed that the majority
of PANF events were during the postpartum
period and during separate hospitalization after
delivery, while miscarriage and abortion were
rarely associated with this complication. These
findings extend prior case series and case reports
describing PANF events mostly in the
postpartum period, often occurring following
hospital discharge [11, 29, 30]. Moreover, the
time to development of PANF, while rapid at
times [31] can be prolonged. In a case series of
PANF following cesarean section by Goepfert
et al. [11], the authors reported the time
difference from the procedure to diagnosis of
NF ranging from 5 to 17 days and exceeding
1 week in 6/9 patients. These findings may
explain the prevalent need for readmission
following delivery hospitalization noted in the
present cohort. However, as noted above,
events prior to postpartum hospitalization
cannot be ascertained and sequence of events
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(i.e., a surgical procedure preceding or following
NF) cannot be inferred in administrative data
sets. Thus, it can only be hypothesized that
preceding procedures (i.e., cesarean section,
episiotomy) may have contributed to
postpartum NF events.
An additional site of infection was reported
in about 1 in 4 PANF hospitalizations, mostly
involving the genital and respiratory tracts. It is
unclear whether reported infections preceded,
followed, or occurred synchronously with
PANF. Previous reports noted additional
infections in some PANF patients. Goepfert
et al. [11] reported an additional site of
infection in 5/9 of their patients, with
chorioamnionitis and endometritis accounting
for most. Appendicitis was reported by
Penninga et al. [9] and in one of three PANF
cases by Schumacher et al. [29]. Other sites of
infection were reported in the general
population with NF in 30% [32] to 76% [33] of
patients.
Microbiology data were not reported in 59%
of PANF hospitalizations. Similar degree of
underreporting was noted by others in
national data sets, with microbiology
information absent in up to 65% [34]. There
was a predominance of monomicrobial
pathogens in this cohort, mostly streptococcal
species with few reports of group A streptococci.
In a recent report by Aronoff et al. [13] on
postpartum invasive streptococcal infections
among women hospitalized in the state of
Florida, based on both required reporting on
invasive streptococcal infections and hospital
discharge data, the investigators did not
identify any PANF events among the described
7 hospitalizations. These findings underscore
the rarity of streptococcal PANF and are in
accord with the very few reported group A
streptococcal isolates in our cohort over a much
longer study period in a much larger
population. The findings in the present study
are in contrast with the polymicrobial etiology
of most events of NF in the general population
[24]. However, these results may have been
affected by underreporting of microbiology,
analysis restricted to PANF hospitalizations
without other reported sites of infection, and
administrative data precluding information on
specimen sources. Previous reports of PANF
varied in microbiology findings. Single case
reports often described monomicrobial
infections [8–10, 29, 31], while case series
tended to report polymicrobial NF [11, 12].
NF is commonly considered to be a critical
illness, with reports in the general population
often focused on patients managed in the ICU
[32]. This study revealed that nearly 60% of
PANF hospitalizations required ICU care. These
findings, coupled with the relatively low
frequency of OF in this cohort, suggest a
broader spectrum of illness among women
with PANF than has been previously described,
likely reflecting focus on more severe illness in
individual case reports. These findings are
similar to those reported by Tillou and
colleagues in the US, describing ICU admission
in 61% of their patients with NF in the general
population [35]. The latter results are also
remarkably similar to reports on NF in the
general population in Australia [33] and New
Zealand [36], showing need for ICU care in 63%
and 56% of their patients, respectively.
Nevertheless, critical care utilization patterns
can vary across countries [37] and regionally
[38], limiting a direct comparison. Indeed, focus
only on ICU-managed NF can underestimate
the burden of NF in the population.
The respiratory, circulatory and renal
systems were the most commonly involved
with OF in the present study. Previous case
series of PANF and studies in the general
population with NF did not systematically
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describe patterns of OF [9–12, 29]. When
selected OFs were systematically examined,
investigators reported renal, circulatory, and
respiratory systems as the most commonly
affected in that order [39]. However, the
investigators restricted their definition of
respiratory failure to patients requiring
invasive mechanical ventilation, thus likely
underestimating the frequency of this
complication and overall OF. In a recent
report by Das et al. [36], focusing on selected
OF, shock and renal failure were each present in
42–43% of their NF cohort. OF was absent in the
majority of PNAF hospitalizations in the present
cohort, likely contributing to the low case
fatality. These findings are similar to those
reported by Endorf and colleagues [39] in the
general population, finding any OF in 30.7 % of
hospitalizations with necrotizing soft tissue
infections, though as noted, the latter study
likely underestimated the rate of OF in their
cohort. Nevertheless, PANF in the patients
described in this study was associated with
substantial morbidity other than OF, as
reflected by prolonged hospital length of stay
and high hospital charges. It can be
hypothesized that the low frequency of OF
reflects the generally healthy population in
the present study. The present study
demonstrated that development of OF
increased nearly threefold during study period.
The frequency of chronic comorbidities rose
markedly during the same period and may have
increased risk of development of OF. This
explanation is supported by occurrence of OF
at a rate nearly twice as high among women
with chronic comorbidities as compared to
those with no reported chronic illness. The
association of OF with chronic illness was also
noted in the general population with NF.
Psoinos et al. [6] reported an increase in
development of OF among patients with NF
over the past decade that was matched by
marked increase in the burden of chronic
comorbidities in a study of a national data set.
We found prolonged hospital length of stay
among PNAF hospitalization, far exceeding the
average 2.6 days for all pregnancy-related
hospitalizations in the state [40]. Hospital
length of stay among patients with PANF,
often prolonged, has been inconsistently
reported by other investigators [9–12]. The
findings of this study are comparable to prior
reports on NF in the general population in the
US [6, 23]. The fiscal burden of PANF has not
been previously reported. The average,
inflation-adjusted (2010 dollars), total hospital
charges per hospitalization in this cohort make
PANF the second most expensive condition in
the state, topped only by respiratory failure
($103,112) [40] and were nearly fivefold higher
than the average charge for pregnancy-related
hospitalization ($21,896) [40]. The average
hospital charges in this study population were
also markedly higher than those reported in the
general population with necrotizing soft tissue
infections, even when adjusted for inflation
[39], though the sources of higher charges
among PANF hospitalization are uncertain.
Although there was no statistically significant
change in hospital charges over the past decade,
the trend of declining charges may have
resulted from increasing care efficiencies, as
reflected by simultaneous downward trend of
hospital length of stay, with no rise in
discharges to other facilities.
The finding of hospital mortality of 2% is
markedly lower than that reported in prior case
series, ranging from 17% [12] to 22% [11].
Possible explanations for the difference may
include improving care, as the cited reports
described patients managed during 1987–1994
[11] and 1986–2000 [12]. In addition, the small
number of patients described (6 [12] and 9 [11])
316 Infect Dis Ther (2014) 3:307–320
limits the precision of case fatality estimates for
the general population, with the 95% CI of case
fatality in these studies overlapping those in the
present cohort. Moreover, the pattern of
difference in case fatality between the cohort
in the present and prior reports of PNAF, is
similar to that noted in the general population
with NF, with large (population-level) studies
describing markedly lower morality rates than
single/few center reports [6]. Indeed, a recent
national study of necrotizing soft tissue
infections by Psoinos et al. [6], hospital
mortality decreased from 9% to 4.9% between
1998 and 2010, though the described
population was older with prevalent chronic
illness.
The results presented here should be
considered in the context of several
limitations. A retrospective design and use of
an administrative data set with its attendant
limitations affect interpretation of these results.
However, the rarity of PANF precludes practical
approach to capture prospectively patient-level
data. In addition, the de-identified data do not
allow accounting for multiple hospitalizations
by the same patient during specific period, nor
to directly account for specific patients
transferred between acute care hospitals.
However, a similar approach with the
aforementioned limitations was used by other
investigators of NF in the general population [6,
39]. In addition, the de-identified nature of the
data did not allow linkage to preceding
pregnancy-associated hospitalizations for the
postpartum hospitalization group, precluding
directly exploring an association of PANF with
surgical interventions and other predisposing
factors during delivery hospitalizations.
Moreover, because time sequence cannot be
established in administrative data sets, a cause
and effect relationship of events cannot be
directly explored even during same
hospitalization. Thus, while previous case
reports and case series suggest a strong
association between postpartum PANF and
preceding surgical procedures, the findings of
the present study of the predominance of
postpartum hospitalizations among the PANF
cohort provide only indirect support for this
association.
The accuracy of case definition of NF in the
present study has been based on ICD-9-CM
coding at reporting hospitals. Administrative
data sets do not provide information on
pathological confirmation of NF diagnosis,
raising a potential of misclassification.
Nevertheless, NF diagnoses were reported very
sparingly (0.004%) among pregnancy-related
hospitalization in this cohort and it is unlikely
that miscoding occurred systematically or
incrementally over time and thus
misclassification is unlikely to explain the rise
in PANF incidence. In addition, the morbidity
burden of PANF in the present study, as judged
by rate of ICU admission and hospital length of
stay is comparable to reports on NF in the
general population [6, 39]. On the other hand,
one cannot exclude underestimation of PANF in
this cohort. Finally, the case identification
approach used here is similar to prior
investigations of NF in the general population
[23, 39].
Microbiology data were not reported in the
majority of PANF hospitalizations in this
cohort, with similar limitation noted by others
[34]. Restricting the analysis to PANF
hospitalizations without additional reported
sites of infection, while helping to exclude
data on microbial isolates in PANF patients
with non-NF infections, further limits the
generalization of the results. Finally, as noted
earlier, administrative data preclude
ascertainment of the actual source of reported
microbiology isolates among PANF
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hospitalizations. These factors affect the
interpretation of these findings. However,
alternative approaches at a population level
can be impractical.
The results of OF in a minority of PANF
hospitalization may reflect underreporting and
thus underestimation of the severity of illness
in this cohort. However, an established broad
method was used to define OF in administrative
data [17]. It is therefore unlikely that OF were
selectively underreported in the state
population.
The use of administrative data in this study
precluded access to information on the timeliness
of diagnosis of PANF and to details, time course,
and appropriateness of antimicrobial therapy and
resuscitative interventions, all of which may vary
across institutions and individual clinicians and
likely have affected the observed resource
utilization and outcomes. However, as noted
earlier, similar constraints affect interpretation of
prior studies in the general population with NF
[23,39].Finally,because thestateofTexasdoesnot
provide tools to convert hospital charges to costs,
hospital charges were reported rather than costs of
care, limiting comparisons with other cost data.
However, the available charge data allowed
comparisons within state population.
CONCLUSION
This research provides the first population-level
study to date of PANF, describing a progressive
rise in its incidence and severity over the past
decade. Most PANF hospitalizations in this
cohort occurred in the postpartum period and
required separate hospitalization post-delivery,
with nearly 1 in 4 hospitalizations associated
with an additional site of infection. The
majority of PANF hospitalizations required
care in an ICU, with common use of life-
support interventions. PANF patients required
prolonged hospitalization with hospital charges
nearly fivefold higher than those for average
pregnancy-related hospitalizations, making
PANF among the costliest hospital diagnoses
in the state. Case fatality was low, but PANF was
associated with substantial residual morbidity
among hospital survivors. Further studies of
PANF are needed in other populations to
provide further insight into this rare
complication.
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